Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Periodic peritonitis. Present management and future prospects.

F Bakir

    Archives of Internal Medicine
    |July 1, 1979
    PubMed
    Summary

    Colchicine effectively treats periodic peritonitis in patients, with optimal daily doses of 1 or 1.5 mg. Stopping medication led to symptom recurrence, and no adverse effects were observed during this study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PITUITARY FUNCTIONS AFTER RECOVERY FROM COVID-19.

    Acta endocrinologica (Bucharest, Romania : 2005)·2024
    Same author

    Analyzing the impact of pulsatile flow on drug release from a single strut of a drug-eluting stent.

    Journal of biomechanics·2023
    Same author

    Asthma in obese women: outcomes and factors involved.

    Journal of investigational allergology & clinical immunology·2011
    Same author

    Blood pool radiopaque polymers. Design considerations.

    Investigative radiology·1994
    Same author

    Systemic lupus erythematosus and periodic peritonitis (FMF)

    British journal of rheumatology·1989
    Same author

    Periodic peritonitis (recurrent polyserositis-or-familial Mediterranean fever) eight decades later.

    The Journal of the Association of Physicians of India·1988

    Area of Science:

    • Rheumatology
    • Internal Medicine
    • Genetics

    Background:

    • Periodic peritonitis is a rare inflammatory condition.
    • Effective long-term management strategies are crucial for improving patient quality of life.

    Purpose of the Study:

    • To evaluate the efficacy and safety of colchicine in treating periodic peritonitis.
    • To determine the optimal dosage and long-term outcomes of colchicine therapy.

    Main Methods:

    • A cohort of 33 patients with periodic peritonitis was observed for 863 patient-months.
    • Patients received colchicine, with dosage adjusted to individual needs (1 or 1.5 mg daily).
    • Treatment outcomes, including recurrence rates and side effects, were meticulously recorded.

    Main Results:

    • All 33 patients responded positively to colchicine treatment.
    • Discontinuation of colchicine invariably led to the precipitation of peritonitis episodes.
    • No adverse side effects were reported during the treatment period.
    • Four healthy infants were born to mothers receiving colchicine during pregnancy.

    Conclusions:

    • Colchicine is a highly effective and safe treatment for periodic peritonitis.
    • Maintaining individualized colchicine dosage is essential for preventing symptom recurrence.
    • Colchicine therapy is safe during pregnancy, with no observed adverse effects on fetal development.

    Related Experiment Videos